Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Reiss

Showing results (471-480 of 509) with videos related to

Pageof 51
Sort By:
The Lancet. HIV|June 6, 2022
Associations of modern initial antiretroviral drug regimens with all-cause mortality in adults with HIV in Europe and North America: a cohort studyAdam Trickey, Lei Zhang, M John Gill, et al.
AIDS (London, England)|April 18, 2003
A randomized trial to study first-line combination therapy with or without a protease inhibitor in HIV-1-infected patientsRemko van Leeuwen, Christine Katlama, Robert L Murphy, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 9, 2021
CD4/CD8 Ratio and the Risk of Kaposi Sarcoma or Non-Hodgkin Lymphoma in the Context of Efficiently Treated Human Immunodeficiency Virus (HIV) Infection: A Collaborative Analysis of 20 European Cohort StudiesFabienne Caby, Marguerite Guiguet, Laurence Weiss, et al.
Plos Medicine|September 10, 2014
Mortality in patients with HIV-1 infection starting antiretroviral therapy in South Africa, Europe, or North America: a collaborative analysis of prospective studiesAndrew Boulle, Michael Schomaker, Margaret T May, et al.
Journal of Viral Hepatitis|June 20, 2023
Contribution of alcohol use in HIV/hepatitis C virus co-infection to all-cause and cause-specific mortality: A collaboration of cohort studiesAdam Trickey, Suzanne M Ingle, Anders Boyd, et al.
Plos One|April 6, 2017
Impact of CD4 and CD8 dynamics and viral rebounds on loss of virological control in HIV controllersFanny Chereau, Yoann Madec, Caroline Sabin, et al.
Journal of the International AIDS Society|January 16, 2018
Increased non-AIDS mortality among persons with AIDS-defining events after antiretroviral therapy initiationApril C Pettit, Mark J Giganti, Suzanne M Ingle, et al.
The Lancet. HIV|October 2, 2015
Comparative effectiveness of immediate antiretroviral therapy versus CD4-based initiation in HIV-positive individuals in high-income countries: observational cohort studySara Lodi, Andrew Phillips, Roger Logan, et al.
Virus Evolution|April 11, 2022
Phylogenetic estimation of the viral fitness landscape of HIV-1 set-point viral loadLele Zhao, Chris Wymant, François Blanquart, et al.
Plos Biology|June 13, 2017
Viral genetic variation accounts for a third of variability in HIV-1 set-point viral load in EuropeFrançois Blanquart, Chris Wymant, Marion Cornelissen, et al.
Pageof 51

Showing results (471-480 of 509) with videos related to

Sort By:
Pageof 51
The Lancet. HIV|June 6, 2022
Associations of modern initial antiretroviral drug regimens with all-cause mortality in adults with HIV in Europe and North America: a cohort studyAdam Trickey, Lei Zhang, M John Gill, et al.
AIDS (London, England)|April 18, 2003
A randomized trial to study first-line combination therapy with or without a protease inhibitor in HIV-1-infected patientsRemko van Leeuwen, Christine Katlama, Robert L Murphy, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 9, 2021
CD4/CD8 Ratio and the Risk of Kaposi Sarcoma or Non-Hodgkin Lymphoma in the Context of Efficiently Treated Human Immunodeficiency Virus (HIV) Infection: A Collaborative Analysis of 20 European Cohort StudiesFabienne Caby, Marguerite Guiguet, Laurence Weiss, et al.
Plos Medicine|September 10, 2014
Mortality in patients with HIV-1 infection starting antiretroviral therapy in South Africa, Europe, or North America: a collaborative analysis of prospective studiesAndrew Boulle, Michael Schomaker, Margaret T May, et al.
Journal of Viral Hepatitis|June 20, 2023
Contribution of alcohol use in HIV/hepatitis C virus co-infection to all-cause and cause-specific mortality: A collaboration of cohort studiesAdam Trickey, Suzanne M Ingle, Anders Boyd, et al.
Plos One|April 6, 2017
Impact of CD4 and CD8 dynamics and viral rebounds on loss of virological control in HIV controllersFanny Chereau, Yoann Madec, Caroline Sabin, et al.
Journal of the International AIDS Society|January 16, 2018
Increased non-AIDS mortality among persons with AIDS-defining events after antiretroviral therapy initiationApril C Pettit, Mark J Giganti, Suzanne M Ingle, et al.
The Lancet. HIV|October 2, 2015
Comparative effectiveness of immediate antiretroviral therapy versus CD4-based initiation in HIV-positive individuals in high-income countries: observational cohort studySara Lodi, Andrew Phillips, Roger Logan, et al.
Virus Evolution|April 11, 2022
Phylogenetic estimation of the viral fitness landscape of HIV-1 set-point viral loadLele Zhao, Chris Wymant, François Blanquart, et al.
Plos Biology|June 13, 2017
Viral genetic variation accounts for a third of variability in HIV-1 set-point viral load in EuropeFrançois Blanquart, Chris Wymant, Marion Cornelissen, et al.
Pageof 51